O
ASLN

OrbiMed’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

OrbiMed’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,530
Closed -$1.75M – 152
2022
Q1 		$1.75M Sell
48,530
-720
-1% -$26.8K 0.03% 134
2021
Q4 		$2.21M Hold
49,250
– – 0.03% 148
2021
Q3 		$3.51M Sell
49,250
-13,750
-22% -$1.56M 0.04% 160
2021
Q2 		$8.32M Hold
63,000
– – 0.08% 133
2021
Q1 		$8.44M Buy
+63,000
New +$7.98M 0.08% 125

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

OrbiMed's ASLN Position: Q2 2022 in Review

OrbiMed sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2022, closing a stake of 48,530 shares — an estimated $1.75M sold.

OrbiMed first reported a position in ASLN in Q1 2021 and held it in 5 quarters. The position peaked at $8.44M in Q1 2021. 27 funds tracked by Wall St. Rank hold ASLN as of Q2 2022.

  • OrbiMed reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • OrbiMed sold 48,530 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2022, an estimated $1.75M.
  • OrbiMed first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 5 quarters.
  • OrbiMed's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $8.44M in Q1 2021.
  • 27 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2022.

Based on OrbiMed's 13F filing for Q2 2022, filed 15 Aug 2022.